Vijay Kumar
Nursing at 126 Ave, Westminster, CO

License number

Colorado 774164

Issued Date

Aug 1, 2016

Renew Date

Aug 1, 2016

Expiration Date

Jan 31, 2017

Type

Certified Nurse Aide

Address

2709W 126Th Ave, Westminster, CO 80020

Personal information

See more information about Vijay Kumar at radaris.com

Name

Address

Phone

Vijay Kumar

9427 W 104Th Way, Broomfield, CO 80021

Vijay Kumar, age 64

4056 Youngfield St, Wheat Ridge, CO 80033

Vijay Kumar

2281 Vaughn Way, Aurora, CO 80014

(720) 747-1008

Professional information

See more information about Vijay Kumar at trustoria.com

Vijay Kumar - Superior, CO

Work:

SkyTouch Technology - Phoenix, AZ
Senior Java Developer Options Clearing Corporation - Keller, TX
Senior Java Developer Texas Health and Human Services - Austin, TX
Senior J2ee developer Verizon - Marlborough, MA
Java Developer Verizon - Tampa, FL
Sr. J2EE Developer Syniverse Technologies - Tampa, FL
Sr. J2EE Web Sphere Developer RCCL - Miami, FL
Java Developer Visa International - Portland, ME
Sr. J2EE Web Sphere Developer FBFS - Salt Lake City, UT
J2EE Developer

Education:

JNTU UNIVERSITY - Macomb, IL
MASTERS in COMPUTER SCIENCE

Vijay Kumar - Superior, CO

Work:

Education:

JNTU UNIVERSITY - Macomb, IL
MASTERS in COMPUTER SCIENCE

Induction Of And Maintenance Of Nucleic Acid Damage In Pathogens Using Riboflavin And Light

US Patent:

7901673, Mar 8, 2011

Filed:

Aug 25, 2003

Appl. No.:

10/648536

Inventors:

Robert Owen Lockerbie - Littleton CO, US
Vijay Kumar - Westminster CO, US
Shawn D. Keil - Wheat Ridge CO, US
Raymond P. Goodrich - Lakewood CO, US

Assignee:

CaridianBCT Biotechnologies, LLC - Lakewood CO

International Classification:

A01N 63/00, A01N 1/02, C12N 5/00, C12N 5/07, C12N 5/10, C12N 5/071

US Classification:

424 9371, 435 2, 435363, 435366, 4353722, 4353723, 435325

Abstract:

A process for damaging and maintaining damage to the nucleic acids of pathogens such as white blood cells, bacteria and viruses which may be contained in blood or blood components. This process comprises adding to the blood or blood component containing pathogens an effective amount of riboflavin, and exposing the fluid to light of an appropriate wavelength to damage the nucleic acid of the pathogen and to substantially maintain the damage to the pathogenic nucleic acids to allow for subsequent transfusion into a recipient.